Estrogen induces cardioprotection in male C57BL/6J mice after acute myocardial infarction via decreased activity of matrix metalloproteinase-9 and increased Akt-Bcl-2 anti-apoptotic signaling

International Journal of Molecular Medicine

Volumn 28, Issue 2, 2011, Pages 231-237

  Cao, Jiumei ^a   Zhu, Tianqi ^a   Lu, Lin ^a   Geng, Liang ^a   Wang, Lingjie ^a   Zhang, Qi ^a   Yang, Ke ^a   Wang, Haibo ^a   Shen, Weifeng ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Apoptosis; Cardio protection; Estrogen; MMP 9; Myocardial infarction

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR BETA; GELATINASE B; PLACEBO; PROTEIN BCL 2; PROTEIN KINASE B;

ACUTE HEART INFARCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CASTRATION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ENZYME ACTIVITY; ENZYME INHIBITION; EVALUATION; HEART MUSCLE CELL; HEART PROTECTION; HEART RUPTURE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REOXYGENATION; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; ENZYME ACTIVATION; ESTROGENS; HEART RUPTURE, POST-INFARCTION; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION;

EID: 79958125707     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2011.681     Document Type: Article

References (25)

1. Nishihama K, Yamada Y, Matsuo H, Segawa T, Watanabe S, Kato K, Yajima K, Hibino T, Yokoi K, Ichihara S, Metoki N, Yoshida H, Satoh K and Nozawa Y: Association of gene polymorphisms with myocardial infarction in individuals with or without conventional coronary risk factors. Int J Mol Med 19: 129-141, 2007.
2. Melle C, Camacho JA, Surber R, Betge S, Von Eggeling F and Zimmer T: Region-specific alterations of global protein expression in the remodelled rat myocardium. Int J Mol Med 18: 1207-1215, 2006.
3. Regitz-Zagrosek V: Therapeutic implications of the gender-specific aspects of cardiovascular disease. Nat Rev Drug Discov 5: 425-438, 2006.
4. Brett KM and Madans JH: Long-term survival after coronary heart disease. Comparisons between men and women in a national sample. Ann Epidemiol 5: 25-32, 1995.
5. Adams KF Jr, Sueta CA, Gheorghiade M, O'Connor CM, Schwartz TA, Koch GG, Uretsky B, Swedberg K, McKenna W, Soler-Soler J and Califf RM: Gender differences in survival in advanced heart failure. Insights from the FIRST study. Circulation 99: 1816-1821, 1999.
6. Barrett-Connor E: Postmenopausal estrogen and heart disease. Atherosclerosis 118 (Suppl): S7-S10, 1995.
7. Shlipak MG, Angeja BG, Go AS, Frederick PD, Canto JG and Grady D: Hormone therapy and in-hospital survival after myocardial infarction in postmenopausal women. Circulation 104: 2300-2304, 2001.
8. Lindenfeld J, Ghali JK, Krause-Steinrauf HJ, Khan S, Adams K, Goldman S, Peberdy MA, Yancy C, Thaneemit-Chen S, Larsen RL, Young J, Lowes B, Rosenberg YD; BEST Investigators: Hormone replacement therapy is associated with improved survival in women with advanced heart failure. J Am Coll Cardiol 42: 1238-1245, 2003.
9. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B and Vittinghoff E: Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 280: 605-613, 1998.
10. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J; Writing Group for the Women's Health Initiative Investigators: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288: 321-333, 2002.
11. Cavasin MA, Tao Z, Menon S and Yang XP: Gender differences in cardiac function during early remodeling after acute myocardial infarction in mice. Life Sci 75: 2181-2192, 2004.
12. Gao XM, Xu Q, Kiriazis H, Dart AM and Du XJ: Mouse model of post-infarct ventricular rupture: time course, strain-and gender-dependency, tensile strength, and histopathology. Cardiovasc Res 65: 469-477, 2005.
13. Tao ZY, Cavasin MA, Yang F, Liu YH and Yang XP: Temporal changes in matrix metalloproteinase expression and inflammatory response associated with cardiac rupture after myocardial infarction in mice. Life Sci 74: 1561-1572, 2004.
14. Urata Y, Ihara Y, Murata H, Goto S, Koji T, Yodoi J, Inoue S and Kondo T: 17Beta-estradiol protects against oxidative stress-induced cell death through the glutathione/glutaredoxin-dependent redox regulation of Akt in myocardiac H9c2 cells. J Biol Chem 281: 13092-13102, 2006.
15. Cavasin MA, Sankey SS, Yu AL, Menon S and Yang XP: Estrogen and testosterone have opposing effects on chronic cardiac remodeling and function in mice with myocardial infarction. Am J Physiol Heart Circ Physiol 284: H1560-H1569, 2003.
16. Patten RD, Pourati I, Aronovitz MJ, Baur J, Celestin F, Chen X, Michael A, Haq S, Nuedling S, Grohe C, Force T, Mendelsohn ME and Karas RH: 17beta-estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phospho-inositide-3 kinase/Akt signaling. Circ Res 95: 692-699, 2004.
17. Korte T, Fuchs M, Arkudas A, Geertz S, Meyer R, Gardiwal A, Klein G, Niehaus M, Krust A, Chambon P, Drexler H, Fink K and Grohé C: Female mice lacking estrogen receptor beta display prolonged ventricular repolarization and reduced ventricular automaticity after myocardial infarction. Circulation 111: 2282-2290, 2005.
18. Iwakura A, Shastry S, Luedemann C, Hamada H, Kawamoto A, Kishore R, Zhu Y, Qin G, Silver M, Thorne T, Eaton L, Masuda H, Asahara T and Losordo DW: Estradiol enhances recovery after myocardial infarction by augmenting incorporation of bone marrow-derived endothelial progenitor cells into sites of ischemia-induced neovascularization via endothelial nitric oxide synthase-mediated activation of matrix metalloproteinase-9. Circulation 113: 1605-1614, 2006.
19. Xu Y, Arenas IA, Armstrong SJ, Plahta WC, Xu H and Davidge ST: Estrogen improves cardiac recovery after ischemia/reperfusion by decreasing tumor necrosis factor-alpha. Cardiovasc Res 69: 836-844, 2006.
20. Zhan E, Keimig T, Xu J, Peterson E, Ding J, Wang F and Yang XP: Dose-dependent cardiac effect of oestrogen replacement in mice post-myocardial infarction. Exp Physiol 93: 982-993, 2008.
21. Wang M, Wang Y, Weil B, Abarbanell A, Herrmann J, Tan J, Kelly M and Meldrum DR: Estrogen receptor beta mediates increased activation of PI3K/Akt signaling and improved myocardial function in female hearts following acute ischemia. Am J Physiol Regul Integr Comp Physiol 296: R972-R978, 2009.
22. Lin J, Steenbergen C, Murphy E and Sun J: Estrogen receptor-beta activation results in S-nitrosylation of proteins involved in cardioprotection. Circulation 120: 245-254, 2009.
23. Cavasin MA, Tao ZY, Yu AL and Yang XP: Testosterone enhances early cardiac remodeling after myocardial infarction, causing rupture and degrading cardiac function. Am J Physiol Heart Circ Physiol 290: H2043-H2050, 2006.
24. Heymans S, Luttun A, Nuyens D, Theilmeier G, Creemers E, Moons L, Dyspersin GD, Cleutjens JP, Shipley M, Angellilo A, Levi M, Nübe O, Baker A, Keshet E, Lupu F, Herbert JM, Smits JF, Shapiro SD, Baes M, Borgers M, Collen D, Daemen MJ and Carmeliet P: Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med 5: 1135-1142, 1999.
25. Ducharme A, Frantz S, Aikawa M, Rabkin E, Lindsey M, Rohde LE, Schoen FJ, Kelly RA, Werb Z, Libby P and Lee RT: Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest 106: 55-62, 2000.